United States Acromegaly Market Report 2017

November 2017 | 107 pages | ID: U592870F15BWEN
QYResearch

Abstracts

In this report, the United States Acromegaly market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Acromegaly in these regions, from 2012 to 2022 (forecast).

United States Acromegaly market competition by top manufacturers/players, with Acromegaly sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG (Switzerland)
• Aegis Therapeutics LLC (US)
• Chiasma Inc (US)
• Crinetics Pharmaceuticals Inc (US)
• Daewoong Pharmaceutical Co Ltd (South Korea)
• Peptron Inc (South Korea)
• Silence Therapeutics Plc (UK)
• Strongbridge Biopharma plc (US)
• Amryt Pharma plc (UK)
• Foresee Pharmaceuticals LLC (US)
• Glide Pharmaceutical Technologies Ltd (US)
• Ionis Pharmaceuticals Inc (US)
• Ipsen SA (France)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Ectopic Acromegaly
• Acromegaly Due to Growth Hormone

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Acromegaly for each application, including

• Hospitals
• Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Acromegaly Market Report 2017

1 ACROMEGALY OVERVIEW

1.1 Product Overview and Scope of Acromegaly
1.2 Classification of Acromegaly by Product Category
  1.2.1 United States Acromegaly Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Acromegaly Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Ectopic Acromegaly
  1.2.4 Acromegaly Due to Growth Hormone
1.3 United States Acromegaly Market by Application/End Users
  1.3.1 United States Acromegaly Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
1.4 United States Acromegaly Market by Region
  1.4.1 United States Acromegaly Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Acromegaly Status and Prospect (2012-2022)
  1.4.3 Southwest Acromegaly Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Acromegaly Status and Prospect (2012-2022)
  1.4.5 New England Acromegaly Status and Prospect (2012-2022)
  1.4.6 The South Acromegaly Status and Prospect (2012-2022)
  1.4.7 The Midwest Acromegaly Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Acromegaly (2012-2022)
  1.5.1 United States Acromegaly Sales and Growth Rate (2012-2022)
  1.5.2 United States Acromegaly Revenue and Growth Rate (2012-2022)

2 UNITED STATES ACROMEGALY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Acromegaly Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Acromegaly Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Acromegaly Average Price by Players/Suppliers (2012-2017)
2.4 United States Acromegaly Market Competitive Situation and Trends
  2.4.1 United States Acromegaly Market Concentration Rate
  2.4.2 United States Acromegaly Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Acromegaly Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACROMEGALY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Acromegaly Sales and Market Share by Region (2012-2017)
3.2 United States Acromegaly Revenue and Market Share by Region (2012-2017)
3.3 United States Acromegaly Price by Region (2012-2017)

4 UNITED STATES ACROMEGALY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Acromegaly Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Acromegaly Revenue and Market Share by Type (2012-2017)
4.3 United States Acromegaly Price by Type (2012-2017)
4.4 United States Acromegaly Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ACROMEGALY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Acromegaly Sales and Market Share by Application (2012-2017)
5.2 United States Acromegaly Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACROMEGALY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG (Switzerland)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Acromegaly Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG (Switzerland) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Aegis Therapeutics LLC (US)
  6.2.2 Acromegaly Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Aegis Therapeutics LLC (US) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Chiasma Inc (US)
  6.3.2 Acromegaly Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Chiasma Inc (US) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Crinetics Pharmaceuticals Inc (US)
  6.4.2 Acromegaly Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Crinetics Pharmaceuticals Inc (US) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Daewoong Pharmaceutical Co Ltd (South Korea)
  6.5.2 Acromegaly Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Daewoong Pharmaceutical Co Ltd (South Korea) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Peptron Inc (South Korea)
  6.6.2 Acromegaly Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Peptron Inc (South Korea) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Silence Therapeutics Plc (UK)
  6.7.2 Acromegaly Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Silence Therapeutics Plc (UK) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Strongbridge Biopharma plc (US)
  6.8.2 Acromegaly Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Strongbridge Biopharma plc (US) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amryt Pharma plc (UK)
  6.9.2 Acromegaly Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amryt Pharma plc (UK) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Foresee Pharmaceuticals LLC (US)
  6.10.2 Acromegaly Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Foresee Pharmaceuticals LLC (US) Acromegaly Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Glide Pharmaceutical Technologies Ltd (US)
6.12 Ionis Pharmaceuticals Inc (US)
6.13 Ipsen SA (France)

7 ACROMEGALY MANUFACTURING COST ANALYSIS

7.1 Acromegaly Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Acromegaly

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Acromegaly Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Acromegaly Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACROMEGALY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Acromegaly Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Acromegaly Sales Volume Forecast by Type (2017-2022)
11.3 United States Acromegaly Sales Volume Forecast by Application (2017-2022)
11.4 United States Acromegaly Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Acromegaly
Figure United States Acromegaly Market Size (K Units) by Type (2012-2022)
Figure United States Acromegaly Sales Volume Market Share by Type (Product Category) in 2016
Figure Ectopic Acromegaly Product Picture
Figure Acromegaly Due to Growth Hormone Product Picture
Figure United States Acromegaly Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Acromegaly by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure United States Acromegaly Market Size (Million USD) by Region (2012-2022)
Figure The West Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Acromegaly Sales (K Units) and Growth Rate (2012-2022)
Figure United States Acromegaly Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Acromegaly Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Acromegaly Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Acromegaly Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Acromegaly Sales Share by Players/Suppliers
Figure 2017 United States Acromegaly Sales Share by Players/Suppliers
Figure United States Acromegaly Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Acromegaly Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Acromegaly Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Acromegaly Revenue Share by Players/Suppliers
Figure 2017 United States Acromegaly Revenue Share by Players/Suppliers
Table United States Market Acromegaly Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Acromegaly Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Acromegaly Market Share of Top 3 Players/Suppliers
Figure United States Acromegaly Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Acromegaly Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Acromegaly Product Category
Table United States Acromegaly Sales (K Units) by Region (2012-2017)
Table United States Acromegaly Sales Share by Region (2012-2017)
Figure United States Acromegaly Sales Share by Region (2012-2017)
Figure United States Acromegaly Sales Market Share by Region in 2016
Table United States Acromegaly Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Acromegaly Revenue Share by Region (2012-2017)
Figure United States Acromegaly Revenue Market Share by Region (2012-2017)
Figure United States Acromegaly Revenue Market Share by Region in 2016
Table United States Acromegaly Price (USD/Unit) by Region (2012-2017)
Table United States Acromegaly Sales (K Units) by Type (2012-2017)
Table United States Acromegaly Sales Share by Type (2012-2017)
Figure United States Acromegaly Sales Share by Type (2012-2017)
Figure United States Acromegaly Sales Market Share by Type in 2016
Table United States Acromegaly Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Acromegaly Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Acromegaly by Type (2012-2017)
Figure Revenue Market Share of Acromegaly by Type in 2016
Table United States Acromegaly Price (USD/Unit) by Types (2012-2017)
Figure United States Acromegaly Sales Growth Rate by Type (2012-2017)
Table United States Acromegaly Sales (K Units) by Application (2012-2017)
Table United States Acromegaly Sales Market Share by Application (2012-2017)
Figure United States Acromegaly Sales Market Share by Application (2012-2017)
Figure United States Acromegaly Sales Market Share by Application in 2016
Table United States Acromegaly Sales Growth Rate by Application (2012-2017)
Figure United States Acromegaly Sales Growth Rate by Application (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Acromegaly Sales Growth Rate (2012-2017)
Figure Novartis AG (Switzerland) Acromegaly Sales Market Share in United States (2012-2017)
Figure Novartis AG (Switzerland) Acromegaly Revenue Market Share in United States (2012-2017)
Table Aegis Therapeutics LLC (US) Basic Information List
Table Aegis Therapeutics LLC (US) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aegis Therapeutics LLC (US) Acromegaly Sales Growth Rate (2012-2017)
Figure Aegis Therapeutics LLC (US) Acromegaly Sales Market Share in United States (2012-2017)
Figure Aegis Therapeutics LLC (US) Acromegaly Revenue Market Share in United States (2012-2017)
Table Chiasma Inc (US) Basic Information List
Table Chiasma Inc (US) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chiasma Inc (US) Acromegaly Sales Growth Rate (2012-2017)
Figure Chiasma Inc (US) Acromegaly Sales Market Share in United States (2012-2017)
Figure Chiasma Inc (US) Acromegaly Revenue Market Share in United States (2012-2017)
Table Crinetics Pharmaceuticals Inc (US) Basic Information List
Table Crinetics Pharmaceuticals Inc (US) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Crinetics Pharmaceuticals Inc (US) Acromegaly Sales Growth Rate (2012-2017)
Figure Crinetics Pharmaceuticals Inc (US) Acromegaly Sales Market Share in United States (2012-2017)
Figure Crinetics Pharmaceuticals Inc (US) Acromegaly Revenue Market Share in United States (2012-2017)
Table Daewoong Pharmaceutical Co Ltd (South Korea) Basic Information List
Table Daewoong Pharmaceutical Co Ltd (South Korea) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd (South Korea) Acromegaly Sales Growth Rate (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd (South Korea) Acromegaly Sales Market Share in United States (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd (South Korea) Acromegaly Revenue Market Share in United States (2012-2017)
Table Peptron Inc (South Korea) Basic Information List
Table Peptron Inc (South Korea) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Peptron Inc (South Korea) Acromegaly Sales Growth Rate (2012-2017)
Figure Peptron Inc (South Korea) Acromegaly Sales Market Share in United States (2012-2017)
Figure Peptron Inc (South Korea) Acromegaly Revenue Market Share in United States (2012-2017)
Table Silence Therapeutics Plc (UK) Basic Information List
Table Silence Therapeutics Plc (UK) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Silence Therapeutics Plc (UK) Acromegaly Sales Growth Rate (2012-2017)
Figure Silence Therapeutics Plc (UK) Acromegaly Sales Market Share in United States (2012-2017)
Figure Silence Therapeutics Plc (UK) Acromegaly Revenue Market Share in United States (2012-2017)
Table Strongbridge Biopharma plc (US) Basic Information List
Table Strongbridge Biopharma plc (US) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Strongbridge Biopharma plc (US) Acromegaly Sales Growth Rate (2012-2017)
Figure Strongbridge Biopharma plc (US) Acromegaly Sales Market Share in United States (2012-2017)
Figure Strongbridge Biopharma plc (US) Acromegaly Revenue Market Share in United States (2012-2017)
Table Amryt Pharma plc (UK) Basic Information List
Table Amryt Pharma plc (UK) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amryt Pharma plc (UK) Acromegaly Sales Growth Rate (2012-2017)
Figure Amryt Pharma plc (UK) Acromegaly Sales Market Share in United States (2012-2017)
Figure Amryt Pharma plc (UK) Acromegaly Revenue Market Share in United States (2012-2017)
Table Foresee Pharmaceuticals LLC (US) Basic Information List
Table Foresee Pharmaceuticals LLC (US) Acromegaly Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Foresee Pharmaceuticals LLC (US) Acromegaly Sales Growth Rate (2012-2017)
Figure Foresee Pharmaceuticals LLC (US) Acromegaly Sales Market Share in United States (2012-2017)
Figure Foresee Pharmaceuticals LLC (US) Acromegaly Revenue Market Share in United States (2012-2017)
Table Glide Pharmaceutical Technologies Ltd (US) Basic Information List
Table Ionis Pharmaceuticals Inc (US) Basic Information List
Table Ipsen SA (France) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acromegaly
Figure Manufacturing Process Analysis of Acromegaly
Figure Acromegaly Industrial Chain Analysis
Table Raw Materials Sources of Acromegaly Major Players/Suppliers in 2016
Table Major Buyers of Acromegaly
Table Distributors/Traders List
Figure United States Acromegaly Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Acromegaly Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Acromegaly Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Acromegaly Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Acromegaly Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Acromegaly Sales Volume (K Units) Forecast by Type in 2022
Table United States Acromegaly Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Acromegaly Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Acromegaly Sales Volume (K Units) Forecast by Application in 2022
Table United States Acromegaly Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Acromegaly Sales Volume Share Forecast by Region (2017-2022)
Figure United States Acromegaly Sales Volume Share Forecast by Region (2017-2022)
Figure United States Acromegaly Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources